Safety and Tolerability of NIM-1324, an Oral, Once-daily LANCL2 Agonist, in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study in Normal Healthy Volunteers

被引：0

作者：

Leber, Andrew ^{[1
]}

Hontecillas, Raquel ^{[1
]}

Juni, Nuria Tubau ^{[1
]}

Bassaganya-Riera, Josep ^{[1
]}

机构：

[1] NIMML Inst, Blacksburg, VA USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2337

引用

页码：4631 / 4632

页数：2

共 50 条

[21] Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial [J].

Pitchford, Lisa M. ;

Driver, Patricia M. ;

Fuller, John C., Jr. ;

Akers, Wendell S. ;

Abumrad, Naji N. ;

Amarnath, Venkataraman ;

Milne, Ginger L. ;

Chen, Sheau-Chiann ;

Ye, Fei ;

Roberts, L. Jackson, II ;

Shoemaker, M. Benjamin ;

Oates, John A. ;

Rathmacher, John A. ;

Boutaud, Olivier .

BMC PHARMACOLOGY & TOXICOLOGY, 2020, 21 (01)

[22] Once-Daily Suvecaltamide Pharmacokinetics, Safety, & Tolerability-Phase 1, Randomized, Double-Blind, Multiple Ascending Dose Study [J].

Markova, S. ;

Baladi, M. ;

Lee, M. ;

Chen, C. .

MOVEMENT DISORDERS, 2024, 39 :S290-S291

[23] A phase 1, randomized, double-blind, placebo-controlled trial investigating the pharmacokinetics, pharmacodynamics, safety and tolerability of oral semaglutide in healthy Chinese subjects [J].

Xie, Panpan ;

Abildlund, Morten T. ;

Baekdal, Tine A. ;

He, Xuemei ;

Lyauk, Yassine K. ;

Patted, Usha Rani H. ;

Ning, Zu ;

Shi, Aixin .

DIABETES OBESITY & METABOLISM, 2024, 26 (08) :3068-3077

[24] Safety, tolerability, and pharmacokinetics of oral (S)-oxiracetam in Chinese healthy volunteers: A randomized, double-blind, controlled phase I study [J].

Zhang, Ting ;

Tao, Yi ;

Pu, Junliang ;

Zhu, Mingxue ;

Wan, Lei ;

Tang, Chengyong .

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 192

[25] Multiple once-daily subcutaneous doses of pasireotide were well tolerated in healthy male volunteers: a randomized, double-blind, placebo-controlled, cross-over, Phase I study [J].

Christoph Beglinger ;

Ke Hu ;

Ying Wang ;

Emmanuel Bouillaud ;

Christelle Darstein ;

Yanfeng Wang ;

Pharis Mohideen .

Endocrine, 2012, 42 :366-374

[26] Multiple once-daily subcutaneous doses of pasireotide were well tolerated in healthy male volunteers: a randomized, double-blind, placebo-controlled, cross-over, Phase I study [J].

Beglinger, Christoph ;

Hu, Ke ;

Wang, Ying ;

Bouillaud, Emmanuel ;

Darstein, Christelle ;

Wang, Yanfeng ;

Mohideen, Pharis .

ENDOCRINE, 2012, 42 (02) :366-374

[27] Glimepiride, a new once-daily sulfonylurea - A double-blind placebo-controlled study of NIDDM patients [J].

Rosenstock, J ;

Samols, E ;

Muchmore, DB ;

Schneider, J ;

Abelove, WA ;

Asplin, CM ;

Bergstrom, RW ;

Berhanu, P ;

Borowski, GD ;

Browning, GV ;

Comstock, JP ;

Friedman, NM ;

Gollapudi, GM ;

Graber, AL ;

Guthrie, RA ;

Henson, BE ;

Hershon, KS ;

Krosnick, A ;

Levin, SR ;

Levy, P ;

Lock, JP ;

Lodewick, PA ;

Mersey, JH ;

Michie, DD ;

Mather, SR ;

Musey, VC ;

Palmer, JP ;

Peters, PJ ;

Poulos, JT ;

Prendergast, JJ ;

Reynolds, LR ;

Roberts, VL ;

Rosenblatt, S ;

Rosenthal, AR ;

Cavanaugh, JJ ;

Schneider, SH ;

Snyder, JW ;

Sweet, RA ;

Vestal, RE .

DIABETES CARE, 1996, 19 (11) :1194-1199

[28] Safety, Tolerability, and Pharmacokinetics of FAAH Inhibitor BIA 10-2474: A Double-Blind, Randomized, Placebo-Controlled Study in Healthy Volunteers [J].

Rocha, Jose-Francisco ;

Santos, Ana ;

Gama, Helena ;

Moser, Paul ;

Falcao, Amilcar ;

Pressman, Peter ;

Wallace Hayes, A. ;

Soares-da-Silva, Patricio .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (02) :391-403

[29] A Randomized, Placebo-Controlled, Double-Blind Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Repeated Doses of Mirogabalin in Healthy Asian Volunteers [J].

Jansen, Mendel ;

Warrington, Steven ;

Dishy, Victor ;

Ohwada, Shoichi ;

Johnson, Lisa ;

Brown, Karen ;

Ishizuka, Hitoshi .

CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (06) :661-669

[30] Metabolic efficacy and safety of once-daily pioglitazone monotherapy in patients with type 2 diabetes:: A double-blind, placebo-controlled study [J].

Scherbaum, WA ;

Göke, B .

HORMONE AND METABOLIC RESEARCH, 2002, 34 (10) :589-595

← 1 2 3 4 5 →